BrainStorm Cell Therapeutics
BCLI
#10935
Rank
C$14.96 M
Marketcap
C$1.36
Share price
6.67%
Change (1 day)
48.53%
Change (1 year)

BrainStorm Cell Therapeutics (BCLI) - Total debt

Total debt on the balance sheet as of June 2026 : C$1.94 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's total debt is C$1.94 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

BrainStorm Cell Therapeutics - Total debt on balance sheet (from 2002 to 2026)

Total debt by year

Year Total debt Change
2025-12-31C$0.28 M-72.43%
2024-12-31C$1.03 M-38.9%
2023-12-31C$1.69 M-69.55%
2022-12-31C$5.55 M-14.2%
2021-12-31C$6.47 M-29.66%
2020-12-31C$9.2 M197.79%
2019-12-31C$3.09 M
2018-12-31N/A
2010-12-31C$0.13 M-64.82%
2009-12-31C$0.38 M-27.72%
2008-12-31C$0.53 M-64.96%
2007-12-31C$1.53 M17.26%
2006-12-31C$1.31 M
2006-03-31C$0.58 M
2004-03-31C$0.04 M31.44%
2003-03-31C$0.03 M90.93%
2002-03-31C$0.01 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Biogen
BIIB
C$11.79 B 607,985.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$37.06 B 1,910,089.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
C$0.16 B 8,159.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
C$1.79 B 92,371.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
C$57.49 M 2,862.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA